Spark Therapeutics: 2Q Earnings Snapshot
PHILADELPHIA (AP) _ Spark Therapeutics Inc. (ONCE) on Tuesday reported second-quarter net income of $80.2 million, after reporting a loss in the same period a year earlier.
The Philadelphia-based company said it had net income of $2.07 per share.
The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 43 cents per share.
The gene therapy developer posted revenue of $25.2 million in the period, missing Street forecasts. Eight analysts surveyed by Zacks expected $29.4 million.
Spark Therapeutics shares have increased 51 percent since the beginning of the year. The stock has risen roughly 1 percent in the last 12 months.